One of the world’s most advanced neuroimaging devices — able to reveal the fine structure…
RSNA News: PI-RADS v2 Effective in Predicting Prostate Cancer
Experts, Clare M. Tempany-Afdhal, MD, Sung Yoon Park, MD, PhD, and Jelle Barentsz, MD, PhD, weigh in on PI-RADS v2 — a simplified scoring system focusing on the detection and exclusion of clinically significant prostate cancer.